Thomas Michael Hansen

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

Cornelius Katona, Thomas Michael Hansen, Christina Kurre Olsen · International Clinical Psychopharmacology · 2012 · 441 citations

Medicine, Pharmacotherapy, Psychiatry +17

Efficacy and safety of arimoclomol in <scp>Niemann‐Pick</scp> disease type C: Results from a double‐blind, randomised, placebo‐controlled, multinational phase 2/3 trial of a novel treatment

Eugen Mengel, Marc C. Patterson, Rosalia Maria Da Riol et al. · Journal of Inherited Metabolic Disease · 2021 · 99 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

<i>Actinobaculum schaalii</i>, a Common Uropathogen in Elderly Patients, Denmark

Steffen Bank, Anders Jensen, Thomas Michael Hansen et al. · Emerging infectious diseases · 2009 · 76 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +8

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Eleftherios Mylonakis, Barnaby Edward Young, David M. Vock et al. · Annals of Internal Medicine · 2022 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Michael Benatar, Thomas Michael Hansen, Dror Rom et al. · The Lancet Neurology · 2024 · 31 citations · Full text

Life Sciences, Neurology, Neuroscience +7